The WGNV TB Vaccine Pipeline covers TB vaccine candidates from preclinical proof-of-concept models to post-marketing studies. Candidates for each category can be viewed by latest stage of development, or on a sortable page that filters candidates by certain categories.
CONTACT: Mike Frick, mike.frick@treatmentactiongroup.org Well-conducted study sponsored by Indian Council of Medical Research did not meet primary efficacy endpoint of preventing microbiologically confirmed TB disease April 15, 2026 — Treatment Action Group (TAG) acknowledges the long-awaited publication of results from…
Over one hundred years after the introduction of BCG, the TB Vaccine Pipeline holds the potential for a new TB vaccine. This crash course covers all the major developments and considerations in the pipeline as we prepare for results from…
Treatment Action Group’s 2024 Tuberculosis Vaccines Pipeline Report surveys major developments in the clinical development of new TB vaccines at this moment of scientific promise and political peril. The pipeline contains 17 candidates and covers vaccines that currently in Phase…
A colorful, infographic guide to understanding and navigating TB vaccines, the pipeline, and the potential impact of a new TB vaccine on the effort to end TB.